Maryland’s Anti–Price-Gouging Law

By on June 9, 2017

It is too soon to tell what the local and national effects of the Maryland law will be. But this effort is part of a growing movement among states to address untenable increases in prescription-drug prices. Other efforts include Louisiana’s recent inquiry invoking U.S. patent and copyright law to ensure the affordability of hepatitis drugs, Nevada’s recent passage of a bill regarding insulin pricing, and other pharmaceutical price-transparency laws proposed in 16 states and Puerto Rico.

Source: Read the full article here at NEJM

About dferry23

You must be logged in to post a comment Login

Leave a Reply